Maria Ekholm
Affilierad forskare
Publikationer
2026
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours
Annals of Oncology, Vol. 37, s. 608-623
(Artikel i tidskrift)
https://dx.doi.org/10.1016/j.annonc.2026.02.008
Prognostic performance of thymidine kinase 1 activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with CDK4/6 and aromatase inhibitors
Breast Cancer Research and Treatment, Vol. 216, Artikel 6
(Artikel i tidskrift)
https://dx.doi.org/10.1007/s10549-025-07879-0
2025
Superparamagnetic tracer and paramagnetic seed for marking of sentinel lymph nodes and index metastatic nodes before neoadjuvant chemotherapy to facilitate subsequent sentinel lymph node biopsy and targeted axillary dissection in breast cancer patients: A feasibility study
SURGICAL ONCOLOGY INSIGHT, Vol. 2, Artikel 100114
(Artikel i tidskrift)
https://dx.doi.org/10.1016/j.soi.2024.100114
Convenient but concerning: patients' experiences of metronomic chemotherapy in metastatic breast cancer
Journal of Psychosocial Oncology Research and Practice, Vol. 7, Artikel e161
(Artikel i tidskrift)
https://dx.doi.org/10.1097/OR9.0000000000000161
Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study
The Breast, Vol. 82, Artikel 104489
(Artikel i tidskrift)
https://dx.doi.org/10.1016/j.breast.2025.104489